Form990-PF

Department of the Treasury
Internal Revenue Service

Return of Private Foundation
or Section 4947(a)(1) Trust Treated as Private Foundation
right arrowDo not enter social security numbers on this form as it may be made public.
right arrowGo to www.irs.gov/Form990PF for instructions and the latest information.
OMB No. 1545-0047
2024
Open to Public Inspection
For calendar year 2024, or tax year beginning 01-01-2024 , and ending 12-31-2024
Name of foundation
DONALD WEESNER CHARITABLE TR UA
 
Number and street (or P.O. box number if mail is not delivered to street address)PO BOX 0634
  Room/suite
City or town, state or province, country, and ZIP or foreign postal code
MILWAUKEE, WI532010634
A Employer identification number

41-6463406
B Telephone number (see instructions)

(651) 466-8040
C right arrow
G Check all that apply:

D 1. Foreign organizations, check here............. right arrow
2. Foreign organizations meeting the 85%
test, check here and attach computation ... right arrow
E right arrow
H Check type of organization:
F right arrow
I Fair market value of all assets at end
of year (from Part II, col. (c),
line 16)right arrow$14,194,002J Accounting method:
 
(Part I, column (d) must be on cash basis.)
Part I Analysis of Revenue and Expenses (The total of amounts in columns (b), (c), and (d) may not necessarily equal the amounts in column (a) (see instructions).) (a) Revenue and
expenses per
books 		(b) Net investment
income 		(c) Adjusted net
income 		(d) Disbursements
for charitable
purposes
(cash basis only)
Revenue 1 Contributions, gifts, grants, etc., received (attach schedule)  
2 Check right arrow.............
3 Interest on savings and temporary cash investments      
4 Dividends and interest from securities... 406,182 404,950  
5a Gross rents............      
b Net rental income or (loss)  
6a Net gain or (loss) from sale of assets not on line 10 541,670
b Gross sales price for all assets on line 6a 3,593,440
7 Capital gain net income (from Part IV, line 2)... 541,670
8 Net short-term capital gain......... 0
9 Income modifications...........  
10a Gross sales less returns and allowances  
b Less: Cost of goods sold....  
c Gross profit or (loss) (attach schedule).....    
11 Other income (attach schedule)....... Click to see attachment
List of Attached Documents:
// Content
17,237 17,237  
12 Total. Add lines 1 through 11........ 965,089 963,857  
Operating and Administrative Expenses 13 Compensation of officers, directors, trustees, etc. 118,748 106,873   11,875
14 Other employee salaries and wages......   0 0 0
15 Pension plans, employee benefits.......   0 0  
16a Legal fees (attach schedule).........       0
b Accounting fees (attach schedule)....... Click to see attachment
List of Attached Documents:
// Content
1,500 0 0 1,500
c Other professional fees (attach schedule).... Click to see attachment
List of Attached Documents:
// Content
4,318     4,318
17 Interest...............       0
18 Taxes (attach schedule) (see instructions)... Click to see attachment
List of Attached Documents:
// Content
14,540 8,350   0
19 Depreciation (attach schedule) and depletion... 0 0  
20 Occupancy..............        
21 Travel, conferences, and meetings.......   0 0  
22 Printing and publications..........   0 0  
23 Other expenses (attach schedule)....... Click to see attachment
List of Attached Documents:
// Content
26,593 5   26,588
24 Total operating and administrative expenses.
Add lines 13 through 23.......... 165,699 115,228 0 44,281
25 Contributions, gifts, grants paid....... 307,000 307,000
26 Total expenses and disbursements. Add lines 24 and 25 472,699 115,228 0 351,281
27 Subtract line 26 from line 12:
a Excess of revenue over expenses and disbursements 492,390
b Net investment income (if negative, enter -0-) 848,629
c Adjusted net income (if negative, enter -0-)... 0
For Paperwork Reduction Act Notice, see instructions.
Cat. No. 11289X Form 990-PF (2024)
Form 990-PF (2024)
Page 2
Part II Balance Sheets Attached schedules and amounts in the description column
should be for end-of-year amounts only. (See instructions.) 		Beginning of year End of year
(a) Book Value (b) Book Value (c) Fair Market Value
Assets 1 Cash—non-interest-bearing.............      
2 Savings and temporary cash investments......... 394,417 808,982 808,982
3 Accounts receivable right arrow  
Less: allowance for doubtful accounts right arrow     0 0
4 Pledges receivable right arrow  
Less: allowance for doubtful accounts right arrow        
5 Grants receivable.................      
6 Receivables due from officers, directors, trustees, and other
disqualified persons (attach schedule) (see instructions).....      
7 Other notes and loans receivable (attach schedule) right arrow  
Less: allowance for doubtful accounts right arrow0      
8 Inventories for sale or use..............      
9 Prepaid expenses and deferred charges..........      
10a Investments—U.S. and state government obligations (attach schedule)      
b Investments—corporate stock (attach schedule)....... 2,856,423 Click to see attachment
List of Attached Documents:
// Content
3,023,790 		6,381,148
c Investments—corporate bonds (attach schedule)....... 751,000    
11 Investments—land, buildings, and equipment: basis right arrow  
Less: accumulated depreciation (attach schedule) right arrow        
12 Investments—mortgage loans.............      
13 Investments—other (attach schedule).......... 6,140,118 Click to see attachment
List of Attached Documents:
// Content
6,802,777 		6,992,364
14 Land, buildings, and equipment: basis right arrow  
Less: accumulated depreciation (attach schedule) right arrow        
15 Other assets (describe right arrow) Click to see attachment
List of Attached Documents:
// Content
14,490 		Click to see attachment
List of Attached Documents:
// Content
11,508 		Click to see attachment
List of Attached Documents:
// Content
11,508
16 Total assets (to be completed by all filers—see the
instructions. Also, see page 1, item I) 10,156,448 10,647,057 14,194,002
Liabilities 17 Accounts payable and accrued expenses..........    
18 Grants payable.................    
19 Deferred revenue.................    
20 Loans from officers, directors, trustees, and other disqualified persons    
21 Mortgages and other notes payable (attach schedule)......    
22 Other liabilities (describe right arrow)    
23 Total liabilities (add lines 17 through 22).........   0
Net Assets or Fund Balances Foundations that follow FASB ASC 958, check here right arrow
and complete lines 24, 25, 29 and 30.
24 Net assets without donor restrictions...........    
25 Net assets with donor restrictions............    
Foundations that do not follow FASB ASC 958, check here right arrow
and complete lines 26 through 30.
26 Capital stock, trust principal, or current funds........ 10,156,448 10,647,057
27 Paid-in or capital surplus, or land, bldg., and equipment fund    
28 Retained earnings, accumulated income, endowment, or other funds    
29 Total net assets or fund balances (see instructions)..... 10,156,448 10,647,057
30 Total liabilities and net assets/fund balances (see instructions). 10,156,448 10,647,057
Part III
Analysis of Changes in Net Assets or Fund Balances
1
Total net assets or fund balances at beginning of year—Part II, column (a), line 29 (must agree with end-of-year figure reported on prior year’s return) ...............
1
10,156,448
2
Enter amount from Part I, line 27a .....................
2
492,390
3
Other increases not included in line 2 (itemize) right arrow
3
0
4
Add lines 1, 2, and 3 ..........................
4
10,648,838
5
Decreases not included in line 2 (itemize) right arrowClick to see attachment
List of Attached Documents:
// Content
5
1,781
6
Total net assets or fund balances at end of year (line 4 minus line 5)—Part II, column (b), line 29 .
6
10,647,057
Form 990-PF (2024)
Form 990-PF (2024)
Page 3
Part IV
Capital Gains and Losses for Tax on Investment Income
(a) List and describe the kind(s) of property sold (e.g., real estate,
2-story brick warehouse; or common stock, 200 shs. MLC Co.)		 (b)
How acquired
P—Purchase
D—Donation 		(c)
Date acquired
(mo., day, yr.) 		(d)
Date sold
(mo., day, yr.)
1 a 1. PROPETRO HLDG CORP   1911-11-11 2024-01-03
b 12. AMPHASTAR PHARMACEUTICALS IN     2024-01-04
c 2. ASBURY AUTOMOTIVE GROUP   2023-07-31 2024-01-04
d 3. ASBURY AUTOMOTIVE GROUP   2021-09-24 2024-01-04
e 7. COHEN STEERS INC   2021-02-25 2024-01-04
17. ROCKET PHARMACEUTICALS INC   2023-09-13 2024-01-04
23. SL GREEN REALTY CORP     2024-01-04
4. WALKER & DUNLOP INC   2023-07-12 2024-01-04
18. AMPHASTAR PHARMACEUTICALS IN     2024-01-08
4. COHEN STEERS INC   2023-12-13 2024-01-08
3. COHEN STEERS INC   2021-02-25 2024-01-08
19. HELMERICH PAYNE INC   2023-06-09 2024-01-08
20. HELMERICH PAYNE INC   2022-10-19 2024-01-08
2. CHORD ENERGY CORPORATION   2021-06-10 2024-01-09
47. PERMIAN RESOURCES CORP CLASS A     2024-01-09
2. ROGERS CORP   2023-04-18 2024-01-12
6. CYMABAY THERAPEUTICS INC   2023-07-05 2024-01-16
7. DIGITALOCEAN HLDGS INC COM   2023-11-28 2024-01-16
4. FRESHWORKS INC CLASS A COM   2024-01-05 2024-01-16
14. FRESHWORKS INC CLASS A COM   2023-12-18 2024-01-16
4. CHORD ENERGY CORPORATION   2021-09-03 2024-01-16
56. PACIFIC BIOSCIENCES OF CALIFORNIA     2024-01-16
23. PERMIAN RESOURCES CORP CLASS A   2023-07-13 2024-01-16
1. ROGERS CORP   2023-03-06 2024-01-16
8. SL GREEN REALTY CORP     2024-01-16
1. EVERCORE INC   2023-01-06 2024-01-18
12. CONMED CORP     2024-01-25
7. DIGITALOCEAN HLDGS INC COM   2023-11-20 2024-01-25
18. DIGITALOCEAN HLDGS INC COM   2023-11-07 2024-01-25
12. OPTION CARE HEALTH INC   2022-09-28 2024-01-25
2. ROGERS CORP     2024-01-25
6. CONMED CORP     2024-01-30
327. DIODES INC   2019-08-05 2024-01-30
6. EXTREME NETWORKS INC COM W/RIGHTS ATTACH   2023-05-31 2024-01-30
8. EXTREME NETWORKS INC COM W/RIGHTS ATTACH   2022-12-08 2024-01-30
10. SAIA INC   2022-01-25 2024-01-30
1. SILICON LABORATORIES INC   2023-03-23 2024-01-30
3. SILICON LABORATORIES INC     2024-01-30
2. ROGERS CORP   2023-02-02 2024-01-31
5. ROGERS CORP     2024-01-31
2. VAXCYTE INC COM   2023-12-28 2024-01-31
9. VAXCYTE INC COM     2024-02-01
7. VERA THERAPEUTICS INC CL A   2024-01-31 2024-02-01
24. EXTREME NETWORKS INC COM W/RIGHTS ATTACH     2024-02-02
11. FASTLY INC CLASS A   2023-11-20 2024-02-02
1. SUPER MICRO COMPUTER INC   2023-12-21 2024-02-02
7. CREDO TECHNOLOGY GROUP HOLDINGS   2023-12-22 2024-02-02
7. VARONIS SYSTEMS INC   2023-12-18 2024-02-05
1. VARONIS SYSTEMS INC   2020-08-07 2024-02-05
6. ADVANCED ENERGY INDS COM   2023-07-31 2024-02-06
10. FASTLY INC CLASS A   2023-12-20 2024-02-06
2. MADRIGAL PHARMACEUTICALS INC     2024-02-06
2. SILICON LABORATORIES INC   2023-12-08 2024-02-06
4. TRANSMEDICS GROUP INC     2024-02-06
20. CREDO TECHNOLOGY GROUP HOLDINGS     2024-02-06
1. AXSOME THERAPEUTICS INC   2022-06-29 2024-02-07
4. E L F BEAUTY INC     2024-02-07
1. ONTO INNOVATION INC   2023-06-08 2024-02-07
1. SUPER MICRO COMPUTER INC   2023-11-17 2024-02-07
31. TEGNA INC   2023-03-28 2024-02-07
66. TEGNA INC     2024-02-07
8. CHART INDUSTRIES INC     2024-02-08
28. QUALYS INC   2018-06-26 2024-02-08
45. SUN COMMUNITIES INC   2023-08-28 2024-02-08
125. SUN COMMUNITIES INC   2019-08-20 2024-02-08
6. VAXCYTE INC COM   2024-01-02 2024-02-08
29. OSCAR HEALTH INC CL A   2024-01-25 2024-02-12
164. PACIFIC BIOSCIENCES OF CALIFORNIA     2024-02-12
3. VAXCYTE INC COM     2024-02-12
10. FASTLY INC CLASS A   2023-12-20 2024-02-14
3. WALKER & DUNLOP INC   2023-07-12 2024-02-14
1. SUPER MICRO COMPUTER INC   2023-11-17 2024-02-16
4. VAXCYTE INC COM   2023-12-28 2024-02-16
21. NEXTRACKER INC CLASS A COM     2024-02-21
1. SUPER MICRO COMPUTER INC   2023-05-24 2024-02-21
8. CREDO TECHNOLOGY GROUP HOLDINGS   2023-12-01 2024-02-21
36. IOVANCE BIOTHERAPEUTICS INC   2024-02-20 2024-02-22
2. VAXCYTE INC COM   2023-12-28 2024-02-23
115. CYMABAY THERAPEUTICS INC     2024-02-27
15. DYNE THERAPEUTICS INC   2024-01-04 2024-02-29
38. COLUMBIA BKG SYS INC     2024-03-04
8. INDEPENDENT BANK CORP (MASS) COM   2023-07-25 2024-03-04
8. INDEPENDENT BANK CORP (MASS) COM   2019-05-28 2024-03-04
2. COMFORT SYS USA INC COM   2021-03-04 2024-03-05
2. E L F BEAUTY INC   2023-10-11 2024-03-05
98. SHOALS TECHNOLOGIES GROUP IN CL A     2024-03-05
35. ALPHATEC HOLDINGS INC   2024-01-25 2024-03-07
48. BANCORP INC DEL     2024-03-07
114. FRESHWORKS INC CLASS A COM     2024-03-07
18. VIKING THERAPEUTICS INC   2024-02-27 2024-03-07
42. BANCORP INC DEL     2024-03-08
26. EMCOR GRP INC COM   2022-11-18 2024-03-11
9. SAIA INC   2022-01-25 2024-03-11
18. E S C O TECHNOLOGIES INC     2024-03-13
29. FASTLY INC CLASS A     2024-03-13
7. ASBURY AUTOMOTIVE GROUP     2024-03-14
45. PARAGON 28 INC COM   2024-01-25 2024-03-14
17. SCHRODINGER INC   2024-02-16 2024-03-15
10. VERA THERAPEUTICS INC CL A     2024-03-15
13.00079 PATHWARD FINANCIAL INC COM     2024-03-18
8.99921 PATHWARD FINANCIAL INC COM   2023-07-14 2024-03-18
3. TRANSMEDICS GROUP INC   2023-01-11 2024-03-20
1. APPFOLIO INC A   2024-03-21 2024-03-27
15. STRUCTURE THERAPEUTICS INC A D R     2024-03-27
17. SYNDAX PHARMACEUTICALS INC   2024-01-25 2024-03-27
36. GOOSEHEAD INSURANCE INC A     2024-03-28
15. KEROS THERAPEUTICS INC COM     2024-03-28
5. SOUTHWEST GAS HOLDINGS INC COM   2022-09-02 2024-03-28
339. BJS WHOLESALE CLUB HOLDINGS INC   2023-03-20 2024-04-02
20. BRAZE INC COM CL A     2024-04-02
6. DECKERS OUTDOOR CORP   2022-07-20 2024-04-02
11. KNIFE RIV HLDG CO   2023-11-01 2024-04-02
4. SUMMIT MATERIALS INC CL A   2021-03-04 2024-04-02
7. WORKIVA INC     2024-04-02
13. WORKIVA INC     2024-04-02
14. ALPINE IMMUNE SCIENCES INC     2024-04-03
8. SPRINGWORKS THERAPEUTICS INC     2024-04-03
72. RADA ELECTR INDS LTD COM     2024-04-04
4. VISTEON CORP   2023-12-18 2024-04-05
9. ALBANY INTL CORP CL A     2024-04-08
11. ALPINE IMMUNE SCIENCES INC   2024-01-31 2024-04-08
6. HELEN OF TROY LTD NEW   2022-11-11 2024-04-09
13. OPTION CARE HEALTH INC     2024-04-11
2. TRANSMEDICS GROUP INC   2023-11-17 2024-04-11
2. TRANSMEDICS GROUP INC   2023-01-11 2024-04-11
7. WALKER & DUNLOP INC   2023-07-12 2024-04-11
9. AMPHASTAR PHARMACEUTICALS IN     2024-04-12
15. NEXTRACKER INC CLASS A COM   2023-05-12 2024-04-15
6. MERITAGE HOMES CORPORATION     2024-04-17
10. MODINE MFG CO COM W/RTS ATTACHED   2024-02-27 2024-04-17
24. STAG INDUSTRIAL INC     2024-04-17
60. STAG INDUSTRIAL INC     2024-04-17
8. TERRENO REALTY CORP     2024-04-17
27. TERRENO REALTY CORP     2024-04-17
5. VERA THERAPEUTICS INC CL A   2024-04-12 2024-04-17
5. DECKERS OUTDOOR CORP   2022-07-20 2024-04-18
32. EMCOR GRP INC COM   2022-11-18 2024-04-18
37. PAYCOM SOFTWARE INC   2023-11-13 2024-04-18
88. PAYCOM SOFTWARE INC   2018-03-28 2024-04-18
5. POWER INTEGRATIONS INC COM W/RIGHTS ATTACHED EXP 2/23/2009   2023-12-11 2024-04-18
9. POWER INTEGRATIONS INC COM W/RIGHTS ATTACHED EXP 2/23/2009   2022-11-11 2024-04-18
1. SILICON LABORATORIES INC   2023-12-08 2024-04-18
2. SILICON LABORATORIES INC   2019-05-28 2024-04-18
29. SCORPIO TANKERS INC     2024-04-18
32. COHEN STEERS INC     2024-04-19
10. COHEN STEERS INC   2023-03-28 2024-04-19
16. COHEN STEERS INC     2024-04-19
1. SUPER MICRO COMPUTER INC   2023-05-24 2024-04-19
1. HELEN OF TROY LTD NEW   2023-10-04 2024-04-24
16. HELEN OF TROY LTD NEW     2024-04-24
55. SKYWARD SPECIALTY INS GROUP IN COM     2024-04-29
1. ALLEGHENY TECHNOLOGIES INC COM   2024-02-16 2024-05-01
15. CHARLES RIV LABORATORIES INTL COM   2017-09-07 2024-05-01
20. CHURCH & DWIGHT INC COM   2007-12-28 2024-05-01
35. ENTEGRIS INC   2020-10-07 2024-05-01
2. EVERCORE INC   2024-04-23 2024-05-01
7. EVERCORE INC     2024-05-01
3. MA COM TECH SOLUTIONS HLDNGS INC   2024-04-01 2024-05-01
3. METTLER-TOLEDO INTL INC   2014-08-19 2024-05-01
1. ONTO INNOVATION INC   2024-04-01 2024-05-01
1. ONTO INNOVATION INC   2024-04-03 2024-05-01
358. PERFICIENT INC   2023-07-21 2024-05-01
16. RAYMOND JAMES FINL INC   2013-04-19 2024-05-01
15. SKYWARD SPECIALTY INS GROUP IN COM   2023-10-04 2024-05-01
1. SUPER MICRO COMPUTER INC   2023-05-24 2024-05-01
4. TRANSMEDICS GROUP INC   2023-11-17 2024-05-01
13. VIKING THERAPEUTICS INC     2024-05-01
2. WEST PHARMACEUTICAL SVCS INC COM   2020-07-02 2024-05-01
3. CACI INTERNATIONAL INC CL A     2024-05-02
4. E L F BEAUTY INC   2024-04-08 2024-05-02
3. TRANSMEDICS GROUP INC   2023-11-14 2024-05-02
2. VIKING THERAPEUTICS INC   2024-01-31 2024-05-02
7. BWX TECHNOLOGIES INC     2024-05-06
13. BWX TECHNOLOGIES INC     2024-05-06
3. COMFORT SYS USA INC COM   2021-03-04 2024-05-06
37. OPTION CARE HEALTH INC     2024-05-06
2. QUALYS INC   2023-11-03 2024-05-06
67. SI BONE INC     2024-05-06
5. TRANSMEDICS GROUP INC   2023-11-14 2024-05-06
4. ULTRAGENYX PHARMACEUTICAL IN   2024-04-11 2024-05-06
6. VARONIS SYSTEMS INC     2024-05-06
19. SHARKNINJA INC     2024-05-06
23. NEXTRACKER INC CLASS A COM     2024-05-08
1. EVERCORE INC   2023-11-03 2024-05-09
5. EVERCORE INC     2024-05-09
11. SHARKNINJA INC     2024-05-09
2. COMFORT SYS USA INC COM   2019-09-16 2024-05-10
3. COMFORT SYS USA INC COM   2019-09-16 2024-05-13
1. MOLINA HEALTHCARE INC   1911-11-11 2024-05-13
3. E L F BEAUTY INC   2023-10-11 2024-05-14
13. SHARKNINJA INC   2023-09-18 2024-05-20
14. KNIFE RIV HLDG CO     2024-05-22
104. PERMIAN RESOURCES CORP CLASS A     2024-05-22
8. SCIENTIFIC GAMES CORP-A COM     2024-05-22
26. SUMMIT MATERIALS INC CL A     2024-05-22
9. SHARKNINJA INC   2023-09-18 2024-05-22
7. E L F BEAUTY INC     2024-05-23
1. ONTO INNOVATION INC   2024-03-04 2024-05-30
30. CREDO TECHNOLOGY GROUP HOLDINGS   2024-03-07 2024-05-30
7. AMKOR TECHNOLOGY INC COM   2024-04-09 2024-05-31
2. APPFOLIO INC A   2024-04-22 2024-05-31
2. MA COM TECH SOLUTIONS HLDNGS INC   2023-05-30 2024-06-04
2. ONTO INNOVATION INC   2023-06-08 2024-06-04
111. PERMIAN RESOURCES CORP CLASS A     2024-06-04
18852.671 CALVERT SHORT DURATION INCOME I   2022-03-02 2024-06-06
79710.028 NYLI FLOATING RATE FUND I     2024-06-06
24384.693 PGIM TOTAL RETURN BOND CL R6   2022-08-12 2024-06-06
2. APPFOLIO INC A   2024-04-22 2024-06-07
23. BWX TECHNOLOGIES INC     2024-06-07
71. ALTIMMUNE INC   2024-01-04 2024-06-10
1. APPFOLIO INC A   2024-04-24 2024-06-10
19. BRUKER CORPORATION   2023-11-13 2024-06-10
340. BRUKER CORPORATION   2023-04-19 2024-06-10
198. DIAMOND OFFSHORE DRILLING INC     2024-06-10
56. IOVANCE BIOTHERAPEUTICS INC     2024-06-10
23. METTLER-TOLEDO INTL INC   2014-08-19 2024-06-10
1. VANDA PHARMACEUTICALS INC   1911-11-11 2024-06-17
94. ALTIMMUNE INC     2024-06-20
5. AMKOR TECHNOLOGY INC COM   2024-04-09 2024-06-20
60. IOVANCE BIOTHERAPEUTICS INC     2024-06-20
3. MA COM TECH SOLUTIONS HLDNGS INC   2023-05-30 2024-06-20
6. VERA THERAPEUTICS INC CL A     2024-06-20
2. CACI INTERNATIONAL INC CL A     2024-06-21
2. ONTO INNOVATION INC   2023-06-08 2024-06-21
2. CACI INTERNATIONAL INC CL A   2022-09-26 2024-06-24
955. CHAMPIONX CORPORATION COM   2023-07-13 2024-06-24
18. INTELLIA THERAPEUTICS INC     2024-06-24
2. ONTO INNOVATION INC   2023-06-08 2024-06-24
16. VERA THERAPEUTICS INC CL A     2024-06-24
5. CLEAN HBRS INC     2024-06-25
69. MP MATLS CORP   2024-04-09 2024-06-25
1. ONTO INNOVATION INC   2023-06-08 2024-06-25
15. SHARKNINJA INC     2024-06-25
4. CLEAN HBRS INC   2022-12-08 2024-06-26
1. ONTO INNOVATION INC   2023-07-10 2024-06-26
1. ONTO INNOVATION INC   2023-06-08 2024-06-26
39. REPLIMUNE GROUP INC   2024-06-10 2024-06-26
116. SAVARA INC   2024-05-02 2024-06-26
15. BIOHAVEN LTD COM     2024-06-26
21. SIMPLY GOOD FOODS COMPANY   2024-01-16 2024-06-27
39. SIMPLY GOOD FOODS COMPANY     2024-06-27
22. FORESTAR GROUP INC     2024-07-03
10. FORESTAR GROUP INC   2023-06-29 2024-07-03
5. MERITAGE HOMES CORPORATION     2024-07-03
3. MERITAGE HOMES CORPORATION   2023-01-25 2024-07-03
6. FTAI AVIATION LTD SHS   2024-04-08 2024-07-09
12. FTAI AVIATION LTD SHS     2024-07-10
16. SCORPIO TANKERS INC     2024-07-11
18. ALLETE INC   2024-05-06 2024-07-15
124. CRANE COMPANY   2023-07-13 2024-07-15
25. EMCOR GRP INC COM   2022-11-18 2024-07-15
514. WILLSCOT MOBIL MINI HLDNG CORP COM   2023-03-10 2024-07-15
108. NVENT ELECTRIC PLC   2023-09-14 2024-07-15
23. AMKOR TECHNOLOGY INC COM     2024-07-16
5. APPFOLIO INC A     2024-07-16
33. BELLRING DISTR LLC COMMON STOCK     2024-07-16
3. EVERCORE INC     2024-07-16
1. MA COM TECH SOLUTIONS HLDNGS INC   2023-05-18 2024-07-16
5. CHORD ENERGY CORPORATION   2024-03-13 2024-07-16
9. CHORD ENERGY CORPORATION     2024-07-16
38. SCIENTIFIC GAMES CORP-A COM     2024-07-16
11. VIKING THERAPEUTICS INC     2024-07-16
4. APPFOLIO INC A   2024-01-09 2024-07-17
922. DOUBLEVERIFY HLDGS INC COM     2024-07-18
35. ENTEGRIS INC   2020-10-07 2024-07-18
153. KEYSIGHT TECHNOLOGIES INC   2018-12-24 2024-07-18
16. MONOLITHIC POWER SYSTEMS INC   2016-10-04 2024-07-18
4. VIRTU FINANCIAL INC CLASS A   2024-07-15 2024-07-18
8. SCORPIO TANKERS INC   2023-08-18 2024-07-18
3. EVERCORE INC   2023-07-12 2024-07-19
1. EVERCORE INC   2023-06-07 2024-07-22
17. OXFORD INDS INC     2024-07-23
5. MA COM TECH SOLUTIONS HLDNGS INC     2024-07-25
5. MA COM TECH SOLUTIONS HLDNGS INC   2023-05-18 2024-07-25
20. VAXCYTE INC COM     2024-07-26
6. VAXCYTE INC COM     2024-07-29
5. CRINETICS PHARMACEUTICALS IN   2024-05-28 2024-07-30
4. MODINE MFG CO COM W/RTS ATTACHED   2024-02-27 2024-07-31
300000. RBC 24M MXEA 2X LBR 202407 7/31/24   2022-07-27 2024-07-31
78. TRIPADVISOR INC COM   2023-12-20 2024-07-31
12690.356 CREDIT SUISSE COMMODITY RETURN   2024-06-06 2024-08-01
2. EVERCORE INC   2023-10-26 2024-08-01
3. EVERCORE INC   2023-06-07 2024-08-01
200000. JPM 24M MXEF 2X LBR MTN LLC 8/01/24   2022-07-27 2024-08-01
5. AZEK CO INC CL A   2024-06-21 2024-08-07
38. AZEK CO INC CL A     2024-08-07
17. HILTON GRAND VACATIONS     2024-08-07
4. HILTON GRAND VACATIONS   2021-05-18 2024-08-07
33. ACADEMY SPORTS OUTDOORS INC COM     2024-08-13
4. LOAR HOLDINGS INC   2024-05-06 2024-08-13
9. HALOZYME THERAPEUTICS INC   2024-07-16 2024-08-14
12. VERONA PHARMA PLC A D R   2023-05-24 2024-08-14
3. FABRINET     2024-08-20
6. HALOZYME THERAPEUTICS INC     2024-08-21
15. CREDO TECHNOLOGY GROUP HOLDINGS     2024-08-21
187. DARDEN RESTAURANTS INC COM   2023-03-09 2024-08-22
8. CREDO TECHNOLOGY GROUP HOLDINGS     2024-08-22
5. HALOZYME THERAPEUTICS INC     2024-08-23
4. INTRA CELLULAR THERAPIES INC   2024-06-18 2024-08-23
1. MADRIGAL PHARMACEUTICALS INC   2023-09-13 2024-08-23
7. PROTAGONIST THERAPEUTICS INC   2023-07-14 2024-08-23
13. STRUCTURE THERAPEUTICS INC A D R   2024-05-01 2024-08-23
3. VAXCYTE INC COM   2023-07-20 2024-08-23
121. STERIS PLC SHS USD     2024-08-28
14. SCORPIO TANKERS INC   2023-08-18 2024-09-04
2. BOOT BARN HOLDINGS INC   2024-06-20 2024-09-10
9. VERONA PHARMA PLC A D R   2023-05-24 2024-09-11
10. CYTOKINETICS INC     2024-09-18
10. VISTEON CORP     2024-09-18
2. FTAI AVIATION LTD SHS   2024-03-18 2024-09-24
13. BOOT BARN HOLDINGS INC     2024-09-27
1. CSW INDUSTRIALS INC   2024-06-24 2024-09-30
13. CONSTRUCTION PARTNERS INC A   2024-03-05 2024-09-30
42. VIRTU FINANCIAL INC CLASS A     2024-10-02
133. AVERY DENNISON CORP COM   2022-11-18 2024-10-03
217. ENTEGRIS INC   2020-10-07 2024-10-03
4000. JPM 24M MXEA 2X LBR MTN LLC 10/03/24   2022-09-28 2024-10-03
247000. JPM 24M MXEF 2X LBR MTN LLC 10/03/24   2022-09-28 2024-10-03
8. MONOLITHIC POWER SYSTEMS INC   2016-10-04 2024-10-03
1. QUALYS INC   2023-11-03 2024-10-07
9. QUALYS INC     2024-10-07
23. ARROWHEAD PHARMACEUTICALS INC     2024-10-09
31. DECKERS OUTDOOR CORP   2022-07-20 2024-10-14
64. ULTRA SALON COSMETICS FRAGRANCE   2022-07-15 2024-10-14
27. EVOLENT HEALTH INC A   2024-08-23 2024-10-18
83. OSCAR HEALTH INC CL A     2024-10-18
110. CHARLES RIV LABORATORIES INTL COM   2017-09-07 2024-10-22
15. AXCELLS TECHNOLOGIES INC     2024-10-23
48. ALLEGHENY TECHNOLOGIES INC COM   2023-06-22 2024-10-24
5. CREDO TECHNOLOGY GROUP HOLDINGS   2023-10-04 2024-10-29
9. ICF INTERNATIONAL INC     2024-11-01
35. CREDO TECHNOLOGY GROUP HOLDINGS     2024-11-01
9. ARCELLX INC COMMON STOCK     2024-11-04
18. VERONA PHARMA PLC A D R     2024-11-04
9. VERONA PHARMA PLC A D R   2023-03-20 2024-11-04
7. CYTOKINETICS INC     2024-11-05
15. CYTOKINETICS INC     2024-11-05
41. ALTAIR ENGINEERING INC A C     2024-11-06
4. ATKORE INC   2023-12-15 2024-11-12
11. ATKORE INC     2024-11-12
6. BRIDGEBIO PHARMA INC   2024-01-30 2024-11-12
5. BRIDGEBIO PHARMA INC     2024-11-12
34. TIDEWATER INC     2024-11-12
9. VERONA PHARMA PLC A D R     2024-11-12
4. HEALTHEQUITY INC   2024-04-11 2024-11-15
15. ICF INTERNATIONAL INC     2024-11-15
14. VERONA PHARMA PLC A D R   2022-09-09 2024-11-15
21. VITA COCO CO INC     2024-11-15
13. NEWAMSTERDAM PHARMA COMPANY   2024-05-01 2024-11-15
7. AXSOME THERAPEUTICS INC     2024-11-19
35. CATALYST PHARMACEUTICAL PART     2024-11-19
14. INTRA CELLULAR THERAPIES INC     2024-11-19
11. VERONA PHARMA PLC A D R   2022-09-09 2024-11-19
5. CREDO TECHNOLOGY GROUP HOLDINGS   2024-07-03 2024-11-19
5. CREDO TECHNOLOGY GROUP HOLDINGS   2023-09-20 2024-11-19
4. CREDO TECHNOLOGY GROUP HOLDINGS   2024-07-12 2024-11-19
17. NEWAMSTERDAM PHARMA COMPANY   2024-05-01 2024-11-19
6. VERONA PHARMA PLC A D R   2022-09-12 2024-11-20
15. TERRENO REALTY CORP     2024-11-21
5. TERRENO REALTY CORP   2020-07-15 2024-11-21
10. CREDO TECHNOLOGY GROUP HOLDINGS     2024-11-21
6. CONSTRUCTION PARTNERS INC A   2023-10-06 2024-11-22
27. VITA COCO CO INC     2024-11-22
48. CORE SCIENTIFIC INC NEW     2024-11-26
6. CREDO TECHNOLOGY GROUP HOLDINGS   2023-12-01 2024-12-02
14. CASEYS GEN STORES INC COM   2024-04-02 2024-12-03
76. POOL CORPORATION     2024-12-03
130. FABRINET   2023-12-26 2024-12-03
3. PROTAGONIST THERAPEUTICS INC   2024-06-10 2024-12-04
23. PROTAGONIST THERAPEUTICS INC   2023-07-03 2024-12-04
43. NEWAMSTERDAM PHARMA COMPANY     2024-12-04
3. CREDO TECHNOLOGY GROUP HOLDINGS   2023-12-01 2024-12-05
18. ATMUS FILTRATION TECHNOLOGY   2024-05-02 2024-12-09
12. CONSTRUCTION PARTNERS INC A   2023-10-06 2024-12-09
3. FTAI AVIATION LTD SHS   2024-03-18 2024-12-09
13. TRANSMEDICS GROUP INC     2024-12-11
28. AMPHASTAR PHARMACEUTICALS IN     2024-12-17
37. HOLOGIC INC COM   2024-08-22 2024-12-17
327. HOLOGIC INC COM   2023-04-19 2024-12-17
14. VERONA PHARMA PLC A D R   2022-09-12 2024-12-17
32. AMPHASTAR PHARMACEUTICALS IN     2024-12-18
127. AUTOLUS THERAPEUTICS PLC A D R   2024-10-11 2024-12-18
6. BRIGHT MINDS BIOSCIENCES INC COM NEW   2024-11-12 2024-12-18
3. KORRO BIO INC   2024-10-16 2024-12-18
22. STRUCTURE THERAPEUTICS INC A D R     2024-12-18
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
(e)
Gross sales price 		(f)
Depreciation allowed
(or allowable) 		(g)
Cost or other basis
plus expense of sale 		(h)
Gain or (loss)
(e) plus (f) minus (g)
a 27     27
b 741   673 68
c 417   451 -34
d 625   590 35
e 503   447 56
487   358 129
1,021   857 164
407   347 60
1,073   950 123
278   272 6
208   192 16
645   662 -17
679   860 -181
315   179 136
618   565 53
231   320 -89
144   72 72
245   210 35
93   88 5
325   339 -14
610   347 263
357   567 -210
295   266 29
112   158 -46
354   297 57
170   120 50
1,118   1,264 -146
231   200 31
594   475 119
373   389 -16
233   312 -79
572   590 -18
22,147   12,481 9,666
100   126 -26
134   163 -29
4,557   2,862 1,695
123   171 -48
367   326 41
231   283 -52
578   603 -25
141   126 15
680   567 113
269   256 13
302   461 -159
248   208 40
579   305 274
153   138 15
320   319 1
46   39 7
636   751 -115
217   188 29
401   435 -34
234   245 -11
346   238 108
408   387 21
93   39 54
670   468 202
158   113 45
684   288 396
445   491 -46
948   1,314 -366
945   1,015 -70
4,693   2,481 2,212
5,600   5,582 18
15,555   17,918 -2,363
444   377 67
499   347 152
1,092   1,239 -147
229   188 41
234   188 46
283   260 23
806   288 518
298   250 48
1,207   971 236
736   167 569
175   152 23
556   431 125
153   125 28
3,712   1,324 2,388
394   252 142
699   932 -233
412   468 -56
412   590 -178
627   138 489
397   208 189
1,282   1,669 -387
447   568 -121
1,800   1,721 79
2,100   2,323 -223
1,420   1,550 -130
1,529   1,446 83
8,226   3,976 4,250
5,220   2,576 2,644
1,828   1,928 -100
381   512 -131
1,424   1,338 86
404   557 -153
434   559 -125
436   275 161
621   720 -99
430   474 -44
221   173 48
248   233 15
637   612 25
388   340 48
2,432   2,690 -258
990   782 208
380   399 -19
25,313   25,665 -352
858   1,191 -333
5,403   1,759 3,644
856   583 273
170   114 56
566   666 -100
1,051   1,033 18
523   384 139
372   405 -33
1,471   1,383 88
439   513 -74
802   781 21
431   296 135
649   607 42
407   420 -13
187   137 50
187   115 72
640   606 34
351   502 -151
674   596 78
899   1,047 -148
860   895 -35
832   894 -62
2,080   1,999 81
443   499 -56
1,495   1,885 -390
203   235 -32
4,154   1,466 2,688
10,884   4,894 5,990
6,922   6,325 597
16,462   9,356 7,106
321   406 -85
578   703 -125
117   122 -5
235   184 51
1,981   1,801 180
2,298   2,160 138
718   606 112
1,154   919 235
753   167 586
90   104 -14
1,444   1,552 -108
1,872   1,573 299
60   46 14
3,541   1,631 1,910
2,126   274 1,852
4,471   2,858 1,613
368   393 -25
1,288   826 462
297   293 4
3,791   810 2,981
186   185 1
186   189 -3
16,772   33,624 -16,852
1,973   469 1,504
531   426 105
740   167 573
470   273 197
993   686 307
733   454 279
1,232   845 387
641   668 -27
370   195 175
152   48 104
686   386 300
1,281   703 578
1,007   207 800
1,110   1,151 -41
339   340 -1
958   1,583 -625
655   325 330
171   205 -34
265   229 36
1,255   920 335
991   883 108
194   141 53
967   567 400
783   492 291
685   86 599
1,001   129 872
28     28
486   313 173
994   540 454
991   723 268
1,624   1,571 53
760   759 1
1,012   652 360
678   374 304
1,263   699 564
223   188 35
753   675 78
225   236 -11
450   431 19
200   121 79
417   225 192
1,665   1,283 382
293,913   301,643 -7,730
708,622   703,549 5,073
290,178   307,110 -16,932
458   431 27
2,036   1,216 820
443   824 -381
232   214 18
1,217   1,094 123
21,773   28,354 -6,581
3,040   2,806 234
444   894 -450
32,905   6,210 26,695
91     91
550   1,019 -469
197   168 29
473   879 -406
316   182 134
214   310 -96
863   547 316
432   225 207
869   544 325
31,325   32,475 -1,150
452   407 45
432   225 207
562   745 -183
1,143   625 518
872   1,209 -337
218   113 105
1,164   608 556
910   473 437
214   111 103
214   113 101
332   352 -20
419   564 -145
525   685 -160
747   884 -137
1,388   1,470 -82
660   755 -95
300   227 73
773   809 -36
464   315 149
623   426 197
1,156   750 406
1,243   853 390
1,143   1,145 -2
18,737   11,362 7,375
9,560   3,823 5,737
19,941   25,767 -5,826
8,453   6,044 2,409
1,025   758 267
1,315   906 409
1,692   733 959
729   396 333
117   60 57
884   817 67
1,591   1,223 368
3,994   3,165 829
631   262 369
1,042   695 347
18,675   36,468 -17,793
4,735   2,858 1,877
22,192   8,642 13,550
13,450   1,270 12,180
109   93 16
595   419 176
722   392 330
241   117 124
1,715   1,629 86
490   463 27
490   297 193
1,673   978 695
497   289 208
261   235 26
474   358 116
385,500   300,000 85,500
1,381   1,702 -321
277,157   300,000 -22,843
472   258 214
708   352 356
235,308   200,000 35,308
181   221 -40
1,374   1,123 251
651   752 -101
153   185 -32
1,674   2,220 -546
286   205 81
514   496 18
326   257 69
825   654 171
370   314 56
534   493 41
28,884   27,391 1,493
284   251 33
311   216 95
298   304 -6
250   192 58
288   150 138
509   512 -3
237   144 93
28,712   10,771 17,941
958   734 224
306   257 49
270   193 77
569   912 -343
932   910 22
258   119 139
2,152   1,221 931
364   271 93
902   645 257
1,297   964 333
28,607   24,977 3,630
24,144   17,717 6,427
5,230   4,000 1,230
329,745   247,000 82,745
7,319   635 6,684
121   170 -49
1,091   1,016 75
407   933 -526
4,997   1,515 3,482
23,552   25,403 -1,851
646   888 -242
1,345   1,475 -130
20,659   11,960 8,699
1,341   1,948 -607
2,944   1,937 1,007
209   80 129
1,369   982 387
1,365   533 832
793   582 211
618   347 271
353   172 181
365   521 -156
783   1,435 -652
4,262   3,487 775
380   624 -244
1,045   1,561 -516
156   224 -68
130   170 -40
1,895   3,208 -1,313
350   156 194
397   324 73
2,005   1,595 410
490   157 333
711   602 109
323   286 37
636   564 72
731   597 134
1,148   1,047 101
402   123 279
208   157 51
208   75 133
174   125 49
401   374 27
235   66 169
905   981 -76
302   272 30
472   312 160
594   244 350
978   730 248
815   761 54
292   114 178
5,853   4,379 1,474
28,572   8,631 19,941
30,502   25,428 5,074
121   99 22
928   463 465
789   921 -132
210   57 153
743   552 191
1,160   488 672
452   179 273
886   1,827 -941
1,135   1,509 -374
2,724   2,967 -243
24,074   27,196 -3,122
592   153 439
1,253   1,348 -95
292   533 -241
236   264 -28
138   236 -98
587   858 -271
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
      211,631
Complete only for assets showing gain in column (h) and owned by the foundation on 12/31/69 (l)
Gains (Col. (h) gain minus
col. (k), but not less than -0-) or
Losses (from col.(h))
(i)
F.M.V. as of 12/31/69 		(j)
Adjusted basis
as of 12/31/69 		(k)
Excess of col. (i)
over col. (j), if any
a       27
b       68
c       -34
d       35
e       56
      129
      164
      60
      123
      6
      16
      -17
      -181
      136
      53
      -89
      72
      35
      5
      -14
      263
      -210
      29
      -46
      57
      50
      -146
      31
      119
      -16
      -79
      -18
      9,666
      -26
      -29
      1,695
      -48
      41
      -52
      -25
      15
      113
      13
      -159
      40
      274
      15
      1
      7
      -115
      29
      -34
      -11
      108
      21
      54
      202
      45
      396
      -46
      -366
      -70
      2,212
      18
      -2,363
      67
      152
      -147
      41
      46
      23
      518
      48
      236
      569
      23
      125
      28
      2,388
      142
      -233
      -56
      -178
      489
      189
      -387
      -121
      79
      -223
      -130
      83
      4,250
      2,644
      -100
      -131
      86
      -153
      -125
      161
      -99
      -44
      48
      15
      25
      48
      -258
      208
      -19
      -352
      -333
      3,644
      273
      56
      -100
      18
      139
      -33
      88
      -74
      21
      135
      42
      -13
      50
      72
      34
      -151
      78
      -148
      -35
      -62
      81
      -56
      -390
      -32
      2,688
      5,990
      597
      7,106
      -85
      -125
      -5
      51
      180
      138
      112
      235
      586
      -14
      -108
      299
      14
      1,910
      1,852
      1,613
      -25
      462
      4
      2,981
      1
      -3
      -16,852
      1,504
      105
      573
      197
      307
      279
      387
      -27
      175
      104
      300
      578
      800
      -41
      -1
      -625
      330
      -34
      36
      335
      108
      53
      400
      291
      599
      872
      28
      173
      454
      268
      53
      1
      360
      304
      564
      35
      78
      -11
      19
      79
      192
      382
      -7,730
      5,073
      -16,932
      27
      820
      -381
      18
      123
      -6,581
      234
      -450
      26,695
      91
      -469
      29
      -406
      134
      -96
      316
      207
      325
      -1,150
      45
      207
      -183
      518
      -337
      105
      556
      437
      103
      101
      -20
      -145
      -160
      -137
      -82
      -95
      73
      -36
      149
      197
      406
      390
      -2
      7,375
      5,737
      -5,826
      2,409
      267
      409
      959
      333
      57
      67
      368
      829
      369
      347
      -17,793
      1,877
      13,550
      12,180
      16
      176
      330
      124
      86
      27
      193
      695
      208
      26
      116
      85,500
      -321
      -22,843
      214
      356
      35,308
      -40
      251
      -101
      -32
      -546
      81
      18
      69
      171
      56
      41
      1,493
      33
      95
      -6
      58
      138
      -3
      93
      17,941
      224
      49
      77
      -343
      22
      139
      931
      93
      257
      333
      3,630
      6,427
      1,230
      82,745
      6,684
      -49
      75
      -526
      3,482
      -1,851
      -242
      -130
      8,699
      -607
      1,007
      129
      387
      832
      211
      271
      181
      -156
      -652
      775
      -244
      -516
      -68
      -40
      -1,313
      194
      73
      410
      333
      109
      37
      72
      134
      101
      279
      51
      133
      49
      27
      169
      -76
      30
      160
      350
      248
      54
      178
      1,474
      19,941
      5,074
      22
      465
      -132
      153
      191
      672
      273
      -941
      -374
      -243
      -3,122
      439
      -95
      -241
      -28
      -98
      -271
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
2 Capital gain net income or (net capital loss) Bracket If gain, also enter in Part I, line 7
If (loss), enter -0- in Part I, line 7		 Bracket 2 541,670
3 Net short-term capital gain or (loss) as defined in sections 1222(5) and (6):
If gain, also enter in Part I, line 8, column (c) (see instructions). If (loss), enter -0-
in Part I, line 8 ................... 		Bracket 3  
Part V
Excise Tax Based on Investment Income (Section 4940(a), 4940(b), 4940(e), or 4948—see instructions)
1a Exempt operating foundations described in section 4940(d)(2), check here right arrow and enter “N/A" on line 1. Bracket for line 1a
Date of ruling or determination letter:   (attach copy of letter if necessary–see instructions) 1 11,796
b All other domestic foundations enter 1.39% (0.0139) of line 27b. Exempt foreign organizations enter 4% (0.04) of Part I, line 12, col. (b)
2 Tax under section 511 (domestic section 4947(a)(1) trusts and taxable foundations only. Others enter -0-) 2 0
3 Add lines 1 and 2........................... 3 11,796
4 Subtitle A (income) tax (domestic section 4947(a)(1) trusts and taxable foundations only. Others enter -0-) 4 0
5 Tax based on investment income. Subtract line 4 from line 3. If zero or less, enter -0- ..... 5 11,796
6 Credits/Payments:
a 2024 estimated tax payments and 2023 overpayment credited to 2024 6a 5,696
b Exempt foreign organizations—tax withheld at source...... 6b 0
c Tax paid with application for extension of time to file (Form 8868)... 6c 6,206
d Backup withholding erroneously withheld .......... 6d  
7 Total credits and payments. Add lines 6a through 6d.............. 7 11,902
8 Enter any penalty for underpayment of estimated tax. Check here if Form 2220 is attached. Click to see attachment
List of Attached Documents:
// Content
8 23
9 Tax due. If the total of lines 5 and 8 is more than line 7, enter amount owed.......right arrow 9  
10 Overpayment. If line 7 is more than the total of lines 5 and 8, enter the amount overpaid...right arrow 10 83
11 Enter the amount of line 10 to be: Credited to 2025 estimated taxright arrow83 Refundedright arrow 11 0
Form 990-PF (2024)
Form 990-PF (2024)
Page 4
Part VI-A
Statements Regarding Activities
1a
During the tax year, did the foundation attempt to influence any national, state, or local legislation or did
Yes
No
it participate or intervene in any political campaign? ....................
1a
 
No
b
Did it spend more than $100 during the year (either directly or indirectly) for political purposes? See the instructions
for the definition.................................
1b
 
No
If the answer is "Yes" to 1a or 1b, attach a detailed description of the activities and copies of any materials
published or distributed by the foundation in connection with the activities.
c
Did the foundation file Form 1120-POL for this year?.....................
1c
 
No
d
Enter the amount (if any) of tax on political expenditures (section 4955) imposed during the year:
(1) On the foundation. right arrow$   (2) On foundation managers.right arrow$  
e
Enter the reimbursement (if any) paid by the foundation during the year for political expenditure tax imposed
on foundation managers.right arrow$  
2
Has the foundation engaged in any activities that have not previously been reported to the IRS?.......
2
 
No
If "Yes," attach a detailed description of the activities.
3
Has the foundation made any changes, not previously reported to the IRS, in its governing instrument, articles
of incorporation, or bylaws, or other similar instruments? If "Yes," attach a conformed copy of the changes....
3
 
No
4a
Did the foundation have unrelated business gross income of $1,000 or more during the year?.........
4a
 
No
b
If "Yes," has it filed a tax return on Form 990-T for this year?...................
4b
 
 
5
Was there a liquidation, termination, dissolution, or substantial contraction during the year?.........
5
 
No
If "Yes," attach the statement required by General Instruction T.
6
Are the requirements of section 508(e) (relating to sections 4941 through 4945) satisfied either:
round bullet By language in the governing instrument, or
round bullet By state legislation that effectively amends the governing instrument so that no mandatory directions
that conflict with the state law remain in the governing instrument? ................
6
Yes
 
7
Did the foundation have at least $5,000 in assets at any time during the year? If "Yes," complete Part II, col. (c),
and Part XIV..................................
7
Yes
 
8a
Enter the states to which the foundation reports or with which it is registered (see instructions)
right arrowMN
b
If the answer is "Yes" to line 7, has the foundation furnished a copy of Form 990-PF to the Attorney
General (or designate) of each state as required by General Instruction G? If "No," attach explanation .
8b
Yes
 
9
Is the foundation claiming status as a private operating foundation within the meaning of section 4942(j)(3)
or 4942(j)(5) for calendar year 2024 or the taxable year beginning in 2024? See the instructions for Part XIII.
If "Yes," complete Part XIII .............................
9
 
No
10
Did any persons become substantial contributors during the tax year? If "Yes," attach a schedule listing their names
and addresses. ...............................
10
 
No
11
At any time during the year, did the foundation, directly or indirectly, own a controlled entity within the
meaning of section 512(b)(13)? If "Yes," attach schedule. See instructions .............
11
 
No
12
Did the foundation make a distribution to a donor advised fund over which the foundation or a disqualified person had
advisory privileges? If "Yes," attach statement. See instructions.................
12
 
No
13
Did the foundation comply with the public inspection requirements for its annual returns and exemption application?
13
Yes
 
Website addressright arrow  
14
The books are in care ofright arrowU S BANK NATIONAL ASSOCIATION Telephone no.right arrow (855) 452-4057

Located atright arrow101 EAST 5TH STREETST PAULMN ZIP+4right arrow55101
15
Section 4947(a)(1) nonexempt charitable trusts filing Form 990-PF in lieu of Form 1041 —check here .........right arrow
and enter the amount of tax-exempt interest received or accrued during the year ........right arrow
15
 
16 At any time during calendar year 2024, did the foundation have an interest in or a signature or other authority over YesNo
a bank, securities, or other financial account in a foreign country? .................
16   No
See the instructions for exceptions and filing requirements for FinCEN Form 114. If "Yes", enter the name of the foreign
country right arrow
Form 990-PF (2024)
Form 990-PF (2024)
Page 5
Part VI-B
Statements Regarding Activities for Which Form 4720 May Be Required
File Form 4720 if any item is checked in the "Yes" column, unless an exception applies.
Yes
No
1a
During the year did the foundation (either directly or indirectly):
(1) Engage in the sale or exchange, or leasing of property with a disqualified person? ...........
1a(1)
 
No
(2) Borrow money from, lend money to, or otherwise extend credit to (or accept it from)
a disqualified person? ..............................
1a(2)
 
No
(3) Furnish goods, services, or facilities to (or accept them from) a disqualified person? ...........
1a(3)
 
No
(4) Pay compensation to, or pay or reimburse the expenses of, a disqualified person? ............
1a(4)
Yes
 
(5) Transfer any income or assets to a disqualified person (or make any of either available
for the benefit or use of a disqualified person)? ......................
1a(5)
 
No
(6) Agree to pay money or property to a government official? (Exception. Check "No"
if the foundation agreed to make a grant to or to employ the official for a period
after termination of government service, if terminating within 90 days.) ...............
1a(6)
 
No
b
If any answer is "Yes" to 1a(1)–(6), did any of the acts fail to qualify under the exceptions described in Regulations
section 53.4941(d)-3 or in a current notice regarding disaster assistance? See instructions ..........
1b
 
No
c
Organizations relying on a current notice regarding disaster assistance check here ........right arrow
d
Did the foundation engage in a prior year in any of the acts described in 1a, other than excepted acts,
that were not corrected before the first day of the tax year beginning in 2024? .............
1d
 
No
2
Taxes on failure to distribute income (section 4942) (does not apply for years the foundation was a private
operating foundation defined in section 4942(j)(3) or 4942(j)(5)):
a
At the end of tax year 2024, did the foundation have any undistributed income (Part XII, lines 6d
and 6e) for tax year(s) beginning before 2024?....................
2a
 
No
If "Yes," list the years right arrow20, 20, 20, 20
b
Are there any years listed in 2a for which the foundation is not applying the provisions of section 4942(a)(2)
(relating to incorrect valuation of assets) to the year’s undistributed income? (If applying section 4942(a)(2)
to all years listed, answer "No" and attach statement—see instructions.) ..............
2b
 
 
c
If the provisions of section 4942(a)(2) are being applied to any of the years listed in 2a, list the years here.
right arrow20, 20, 20, 20
3a
Did the foundation hold more than a 2% direct or indirect interest in any business enterprise at
any time during the year? ..............................
3a
 
No
b
If "Yes," did it have excess business holdings in 2024 as a result of (1) any purchase by the foundation
or disqualified persons after May 26, 1969; (2) the lapse of the 5-year period (or longer period approved
by the Commissioner under section 4943(c)(7)) to dispose of holdings acquired by gift or bequest; or (3)
the lapse of the 10-, 15-, or 20-year first phase holding period? (Use Schedule C, Form 4720, to determine
if the foundation had excess business holdings in 2024.) .....................
3b
 
 
4a
Did the foundation invest during the year any amount in a manner that would jeopardize its charitable purposes?
4a
 
No
b
Did the foundation make any investment in a prior year (but after December 31, 1969) that could jeopardize its
charitable purpose that had not been removed from jeopardy before the first day of the tax year beginning in 2024? ..
4b
 
No
Form 990-PF (2024)
Form 990-PF (2024)
Page 6
Part VI-B
Statements Regarding Activities for Which Form 4720 May Be Required (continued)
5a
During the year did the foundation pay or incur any amount to:
Yes
No
(1) Carry on propaganda, or otherwise attempt to influence legislation (section 4945(e))? ..........
5a(1)
 
No
(2) Influence the outcome of any specific public election (see section 4955); or to carry
on, directly or indirectly, any voter registration drive? ....................
5a(2)
 
No
(3) Provide a grant to an individual for travel, study, or other similar purposes? .............
5a(3)
 
No
(4) Provide a grant to an organization other than a charitable, etc., organization described
in section 4945(d)(4)(A)? See instructions ........................
5a(4)
 
No
(5) Provide for any purpose other than religious, charitable, scientific, literary, or
educational purposes, or for the prevention of cruelty to children or animals? .............
5a(5)
 
No
b
If any answer is "Yes" to 5a(1)–(5), did any of the transactions fail to qualify under the exceptions described in
Regulations section 53.4945 or in a current notice regarding disaster assistance? See instructions ........
5b
 
 
c
Organizations relying on a current notice regarding disaster assistance check .........right arrow
d
If the answer is "Yes" to question 5a(4), does the foundation claim exemption from the
tax because it maintained expenditure responsibility for the grant? .................
5d
 
 
If "Yes," attach the statement required by Regulations section 53.4945–5(d).
6a
Did the foundation, during the year, receive any funds, directly or indirectly, to pay premiums on
a personal benefit contract? .............................
6a
 
No
b
Did the foundation, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ....
6b
 
No
If "Yes" to 6b, file Form 8870.
7a
At any time during the tax year, was the foundation a party to a prohibited tax shelter transaction?
7a
 
No
b
If "Yes", did the foundation receive any proceeds or have any net income attributable to the transaction? .....
7b
 
 
8
Is the foundation subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or
excess parachute payment during the year? .........................
8
 
No
Part VII
Information About Officers, Directors, Trustees, Foundation Managers, Highly Paid Employees,
and Contractors
1 List all officers, directors, trustees, foundation managers and their compensation. See instructions
(a) Name and address (b) Title, and average
hours per week
devoted to position 		(c) Compensation
 (If not paid, enter
-0-) 		(d) Contributions to employee benefit plans and deferred compensation (e) Expense account,
other allowances
US BANK N A CORPORATE TRUSTEE
1 		118,748    
101 EAST 5TH STREET
ST PAUL,MN55101
2 Compensation of five highest-paid employees (other than those included on line 1—see instructions). If none, enter “NONE."
(a) Name and address of each employee paid more than $50,000 (b) Title, and average
hours per week
devoted to position 		(c) Compensation (d) Contributions to
employee benefit
plans and deferred
compensation 		(e) Expense account,
other allowances
NONE
Total number of other employees paid over $50,000...................right arrow 0
Form 990-PF (2024)
Form 990-PF (2024)
Page 7
Part VII
Information About Officers, Directors, Trustees, Foundation Managers, Highly Paid Employees,
and Contractors (continued)
3 Five highest-paid independent contractors for professional services (see instructions). If none, enter "NONE".
(a) Name and address of each person paid more than $50,000 (b) Type of service (c) Compensation
NONE
Total number of others receiving over $50,000 for professional services.............right arrow0
Part VIII-A
Summary of Direct Charitable Activities
List the foundation’s four largest direct charitable activities during the tax year. Include relevant statistical information such as the number of organizations and other beneficiaries served, conferences convened, research papers produced, etc. Expenses
1  
2  
3  
4  
Part VIII-B
Summary of Program-Related Investments (see instructions)
Describe the two largest program-related investments made by the foundation during the tax year on lines 1 and 2. Amount
1  
2  
All other program-related investments. See instructions.
3  
Total. Add lines 1 through 3.........................right arrow  
Form 990-PF (2024)
Form 990-PF (2024)
Page 8
Part IX
Minimum Investment Return (All domestic foundations must complete this part. Foreign foundations, see instructions.)
1
Fair market value of assets not used (or held for use) directly in carrying out charitable, etc.,
purposes:
a
Average monthly fair market value of securities...................
1a
13,634,575
b
Average of monthly cash balances.......................
1b
469,179
c
Fair market value of all other assets (see instructions)................
1c
0
d
Total (add lines 1a, b, and c).........................
1d
14,103,754
e
Reduction claimed for blockage or other factors reported on lines 1a and
1c (attach detailed explanation) .............
1e
0
2
Acquisition indebtedness applicable to line 1 assets..................
2
0
3
Subtract line 2 from line 1d.........................
3
14,103,754
4
Cash deemed held for charitable activities. Enter 1.5% (0.015) of line 3 (for greater amount, see
instructions) .............................
4
211,556
5
Net value of noncharitable-use assets. Subtract line 4 from line 3. ............
5
13,892,198
6
Minimum investment return. Enter 5% (0.05) of line 5................
6
694,610
Part X
Distributable Amount (see instructions) (Section 4942(j)(3) and (j)(5) private operating foundations and certain foreign organizations check here right arrow and do not complete this part.)
1
Minimum investment return from Part IX, line 6..................
1
694,610
2a
Tax on investment income for 2024 from Part V, line 5 .......
2a
11,796
b
Income tax for 2024. (This does not include the tax from Part V.) ...
2b
 
c
Add lines 2a and 2b............................
2c
11,796
3
Distributable amount before adjustments. Subtract line 2c from line 1............
3
682,814
4
Recoveries of amounts treated as qualifying distributions................
4
0
5
Add lines 3 and 4............................
5
682,814
6
Deduction from distributable amount (see instructions).................
6
0
7
Distributable amount as adjusted. Subtract line 6 from line 5. Enter here and on Part XII, line 1 ...
7
682,814
Part XI
Qualifying Distributions (see instructions)
1
Amounts paid (including administrative expenses) to accomplish charitable, etc., purposes:
a
Expenses, contributions, gifts, etc.—total from Part I, column (d), line 26 ..........
1a
351,281
b
Program-related investments—total from Part VIII-B..................
1b
0
2
Amounts paid to acquire assets used (or held for use) directly in carrying out charitable, etc.,
purposes...............................
2
0
3
Amounts set aside for specific charitable projects that satisfy the:
a
Suitability test (prior IRS approval required)....................
3a
0
b
Cash distribution test (attach the required schedule) .................
3b
0
4
Qualifying distributions. Add lines 1a through 3b. Enter here and on Part XII, line 4. .......
4
351,281
Form 990-PF (2024)
Form 990-PF (2024)
Page 9
Part XII
Undistributed Income (see instructions)
(a)
Corpus 		(b)
Years prior to 2023 		(c)
2023 		(d)
2024
1 Distributable amount for 2024 from Part X, line 7 682,814
2 Undistributed income, if any, as of the end of 2024:
a Enter amount for 2023 only....... 0
b Total for prior years:20 , 20, 20 0
3 Excess distributions carryover, if any, to 2024:
a From 2019...... 0
b From 2020...... 12,840
c From 2021...... 0
d From 2022...... 91,410
e From 2023...... 28,445
f Total of lines 3a through e ........ 132,695
4Qualifying distributions for 2024 from Part
XI, line 4: right arrow$ 351,281
a Applied to 2023, but not more than line 2a 0
b Applied to undistributed income of prior years
(Election required—see instructions)..... 		0
c Treated as distributions out of corpus (Election
required—see instructions)........ 		0
d Applied to 2024 distributable amount..... 351,281
e Remaining amount distributed out of corpus 0
5 Excess distributions carryover applied to 2024. 132,695 132,695
(If an amount appears in column (d), the
same amount must be shown in column (a).)
6Enter the net total of each column as
indicated below:
a Corpus. Add lines 3f, 4c, and 4e. Subtract line 5 0
b Prior years’ undistributed income. Subtract
line 4b from line 2b .......... 		0
c Enter the amount of prior years’ undistributed
income for which a notice of deficiency has
been issued, or on which the section 4942(a)
tax has been previously assessed...... 		0
d Subtract line 6c from line 6b. Taxable amount
—see instructions ........... 		0
e Undistributed income for 2023. Subtract line
4a from line 2a. Taxable amount—see
instructions ............. 		0
f Undistributed income for 2024. Subtract
lines 4d and 5 from line 1. This amount must
be distributed in 2025 .......... 		198,838
7 Amounts treated as distributions out of
corpus to satisfy requirements imposed by
section 170(b)(1)(F) or 4942(g)(3) (Election may
be required - see instructions) ....... 		0
8 Excess distributions carryover from 2019 not
applied on line 5 or line 7 (see instructions) ... 		0
9 Excess distributions carryover to 2025.
Subtract lines 7 and 8 from line 6a ...... 		0
10 Analysis of line 9:
a Excess from 2020.... 0
b Excess from 2021.... 0
c Excess from 2022.... 0
d Excess from 2023.... 0
e Excess from 2024.... 0
Form 990-PF (2024)
Form 990-PF (2024)
Page 10
Part XIII
Private Operating Foundations (see instructions and Part VI-A, question 9)
1a If the foundation has received a ruling or determination letter that it is a private operating
foundation, and the ruling is effective for 2024, enter the date of the ruling ...... right arrow
 
b Check box to indicate whether the organization is a private operating foundation described in section or
2a Enter the lesser of the adjusted net
income from Part I or the minimum
investment return from Part IX for each
year listed .......... 		Tax year Prior 3 years (e) Total
(a) 2024 (b) 2023 (c) 2022 (d) 2021
         
b 85% (0.85) of line 2a .........          
c Qualifying distributions from Part XI,
line 4 for each year listed ..... 		         
d Amounts included in line 2c not used directly
for active conduct of exempt activities .......... 		         
e Qualifying distributions made directly
for active conduct of exempt activities.
Subtract line 2d from line 2c .... 		         
3 Complete 3a, b, or c for the
alternative test relied upon:
a “Assets" alternative test—enter:
(1) Value of all assets ......          
(2) Value of assets qualifying
under section 4942(j)(3)(B)(i)		          
b “Endowment" alternative test— enter 2/3
of minimum investment return shown in
Part IX, line 6 for each year listed .. 		         
c “Support" alternative test—enter:
(1) Total support other than gross
investment income (interest,
dividends, rents, payments
on securities loans (section
512(a)(5)), or royalties) .... 		         
(2) Support from general public
and 5 or more exempt
organizations as provided in
section 4942(j)(3)(B)(iii).... 		         
(3) Largest amount of support
from an exempt organization		          
(4) Gross investment income          
Part XIV
Supplementary Information (Complete this part only if the foundation had $5,000 or more in
assets at any time during the year—see instructions.)
1Information Regarding Foundation Managers:
aList any managers of the foundation who have contributed more than 2% of the total contributions received by the foundation
before the close of any tax year (but only if they have contributed more than $5,000). (See section 507(d)(2).)
NONE
bList any managers of the foundation who own 10% or more of the stock of a corporation (or an equally large portion of the
ownership of a partnership or other entity) of which the foundation has a 10% or greater interest.
NONE
2Information Regarding Contribution, Grant, Gift, Loan, Scholarship, etc., Programs:
Check here right arrow if the foundation only makes contributions to preselected charitable organizations and does not accept
unsolicited requests for funds. If the foundation makes gifts, grants, etc. to individuals or organizations under
other conditions, complete items 2a, b, c, and d. See instructions
aThe name, address, and telephone number or email address of the person to whom applications should be addressed:
bThe form in which applications should be submitted and information and materials they should include:
cAny submission deadlines:
dAny restrictions or limitations on awards, such as by geographical areas, charitable fields, kinds of institutions, or other
factors:
Form 990-PF (2024)
Form 990-PF (2024)
Page 11
Part XIV
Supplementary Information (continued)
3 Grants and Contributions Paid During the Year or Approved for Future Payment
Recipient If recipient is an individual,
show any relationship to
any foundation manager
or substantial contributor
 Foundation
status of
recipient 		Purpose of grant or
contribution 		Amount
Name and address (home or business)
aPaid during the year

WOLF RIDGE ENVIRONMENTAL LEARNING CENTER

6282 CRANBERRY RD
FINLAND,MN55603 		NONE PC GENERAL OPERATING 51,000

GREAT RIVER GREENING

251 STARKEY ST STE 220
SAINT PAUL,MN551071874 		NONE PC GENERAL OPERATING 61,000

GREAT LAKES AQUARIUM

353 HARBOR DR
DULUTH,MN55802 		NONE PC GENERAL OPERATING 20,000

WILDLIFE REHABILITATION CENTER

2530 DALE ST
ROSEVILE,MN55113 		NONE PC GENERAL OPERATING 60,000

TWIN CITIES PBS

172 E FOURTH ST
ST PAUL,MN55101 		NONE PC GENERAL OPERATING 35,000

THOMAS IRVINE DODGE NATURE CENTER

365 MARIE AVE W
WEST SAINT PAUL,MN55118 		NONE PC GENERAL OPERATING 50,000

TRUE FRIENDS

10509 108TH STE NW
ANNANDALE,MN55302 		NONE PC GENERAL OPERATING 25,000

LAKE SUPERIOR ZOO

7210 FREMONT ST
DULUTH,MN55807 		NONE PC GENERAL OPERATING 5,000
Total .................................right arrow 3a 307,000
bApproved for future payment
Total ................................. right arrow 3b  
Form 990-PF (2024)
Form 990-PF (2024)
Page 12
Part XV-A
Analysis of Income-Producing Activities
Enter gross amounts unless otherwise indicated. Unrelated business income Excluded by section 512, 513, or 514 (e)
Related or exempt
function income
(See instructions.)
1Program service revenue: (a)
Business code 		(b)
Amount 		(c)
Exclusion code 		(d)
Amount
a
b
c
d
e
f
gFees and contracts from government agencies          
2 Membership dues and assessments ....          
3 Interest on savings and temporary cash
investments ........... 		         
4 Dividends and interest from securities ....     14 406,182  
5 Net rental income or (loss) from real estate:
aDebt-financed property......          
bNot debt-financed property.....          
6 Net rental income or (loss) from personal property          
7 Other investment income .....          
8 Gain or (loss) from sales of assets other than
inventory ............ 		    18 541,670  
9 Net income or (loss) from special events:          
10 Gross profit or (loss) from sales of inventory          
11 Other revenue:
aCARLYLE PE DISTRIB 		    1 16,542  
bOTHER INCOME     1 695  
c
d
e
12 Subtotal. Add columns (b), (d), and (e) ..   965,089  
13Total. Add line 12, columns (b), (d), and (e)..................
13
965,089
(See worksheet in line 13 instructions to verify calculations.)
Part XV-B
Relationship of Activities to the Accomplishment of Exempt Purposes
Line No.
DownArrow 		Explain below how each activity for which income is reported in column (e) of Part XV-A contributed importantly to
the accomplishment of the foundation’s exempt purposes (other than by providing funds for such purposes). (See
instructions.)
Form 990-PF (2024)
Form 990-PF (2024)
Page 13
Part XVI
Information Regarding Transfers To and Transactions and Relationships With Noncharitable Exempt Organizations
1
Did the organization directly or indirectly engage in any of the following with any other organization described in section 501(c) (other than section 501(c)(3) organizations) or in section 527, relating to political organizations?
Yes
No
a
Transfers from the reporting foundation to a noncharitable exempt organization of:
(1) Cash...................................
1a(1)
 
No
(2) Other assets.................................
1a(2)
 
No
b
Other transactions:
(1) Sales of assets to a noncharitable exempt organization....................
1b(1)
 
No
(2) Purchases of assets from a noncharitable exempt organization..................
1b(2)
 
No
(3) Rental of facilities, equipment, or other assets.......................
1b(3)
 
No
(4) Reimbursement arrangements...........................
1b(4)
 
No
(5) Loans or loan guarantees.............................
1b(5)
 
No
(6) Performance of services or membership or fundraising solicitations................
1b(6)
 
No
c
Sharing of facilities, equipment, mailing lists, other assets, or paid employees..............
1c
 
No
d
If the answer to any of the above is "Yes," complete the following schedule. Column (b) should always show the fair market value
of the goods, other assets, or services given by the reporting foundation. If the foundation received less than fair market value
in any transaction or sharing arrangement, show in column (d) the value of the goods, other assets, or services received.
(a) Line No. (b) Amount involved (c) Name of noncharitable exempt organization (d) Description of transfers, transactions, and sharing arrangements
2a
Is the foundation directly or indirectly affiliated with, or related to, one or more tax-exempt organizations
described in section 501(c) (other than section 501(c)(3)) or in section 527? ...........
b
If "Yes," complete the following schedule.

(a) Name of organization (b) Type of organization (c) Description of relationship
Sign Here
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than taxpayer) is based on all information of which preparer has any knowledge.
right arrow right arrow
May the IRS discuss this return
with the preparer shown below?
See instructions.
Signature of officer or trustee Date Title
Paid Preparer Use Only Print/Type preparer's name Preparer's Signature Date Check if self-
employed right arrow		 PTIN
Firm's name Right Arrow
 Firm's EIN Right Arrow
Firm's address Right Arrow


 Phone no.
Form 990-PF (2024)
Additional Data


Software ID:  
Software Version:  


Form 990PF - Special Condition Description:
Special Condition Description

TY 2024 AccountingFeesSchedule
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Category Amount Net Investment Income Adjusted Net Income Disbursements for Charitable Purposes
TAX PREPARATION FEE (NON-ALLOC 1,500     1,500

TY 2024 InvestmentsCorpBondsSchedule
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Name of Bond End of Year Book Value End of Year Fair Market Value
48133LRG9 JPM 24M MXEF 2X LBR    
48133MZ52 JPM 24M MXEA 2X LBR    
78016FPE8 RBC 24M MXEA 2X LBR    
48133MZ78 JPM 24M MXEF 2X LBR    

TY 2024 InvestmentsCorpStockSchedule
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Name of Stock End of Year Book Value End of Year Fair Market Value
761152107 RESMED INC 11,058 33,389
655844108 NORFOLK SOUTHN CORP 29,581 207,240
857477103 STATE STR CORP 64,388 139,079
478160104 JOHNSON JOHNSON 41,930 168,193
609839105 MONOLITHIC POWER SYS 2,778 20,710
65339F101 NEXTERA ENERGY INC 34,928 460,537
592688105 METTLER-TOLEDO INTL    
17275R102 CISCO SYSTEMS INC 95,207 314,411
754730109 RAYMOND JAMES FINL I 10,976 40,230
949746101 WELLS FARGO CO NEW C 102,162 382,738
438516106 HONEYWELL INTL INC 37,163 221,146
171340102 CHURCH AND DWIGHT CO 3,832 29,424
30231G102 EXXON MOBIL CORP 77,830 297,646
594918104 MICROSOFT CORP 43,259 761,229
216648402 COOPER COS INC    
291011104 EMERSON ELECTRIC CO 65,371 371,790
G5960L103 MEDTRONIC PLC 229,223 239,640
717081103 PFIZER INC 98,424 99,753
73278L105 POOL CORPORATION    
217204106 COPART INC COM 6,916 36,156
159864107 CHARLES RIV LABORATO    
254543101 DIODES INC    
874054109 TAKE-TWO INTERACTIVE 23,635 32,030
74758T303 QUALYS INC 21,151 26,642
49338L103 KEYSIGHT TECHNOLOGIE    
70432V102 PAYCOM SOFTWARE INC    
866674104 SUN COMMUNITIES INC    
453836108 INDEPENDENT BK CORP 4,873 5,071
16115Q308 CHART INDUSTRIES INC 1,880 3,435
92839U206 VISTEON CORP    
879360105 TELEDYNE TECHNOLOGIE 18,194 27,848
199908104 COMFORT SYS USA INC    
197236102 COLUMBIA BKG SYS INC 5,795 4,970
88146M101 TERRENO REALTY CORP 1,744 2,011
057665200 BALCHEM CORP 1,395 2,608
207410101 CONMED CORP    
012348108 ALBANY INTL CORP CL 981 1,679
91324P102 UNITEDHEALTH GROUP I 102,299 240,284
099502106 BOOZ ALLEN HAMILTON 19,013 31,660
G8473T100 STERIS PLC SHS USD    
05464T104 AXSOME THERAPEUTICS 1,243 1,946
826919102 SILICON LABORATORIES    
19247A100 COHEN STEERS INC    
29444U700 EQUINIX INC 153,453 212,150
29362U104 ENTEGRIS INC    
93148P102 WALKER & DUNLOP INC 3,261 3,500
29977A105 EVERCORE INC    
97650W108 WINTRUST FINL CORP C 4,015 7,483
05550J101 BJS WHOLESALE CLUB H    
739276103 POWER INTEGRATIONS I    
955306105 WEST PHARMACEUTICAL 18,833 27,187
922280102 VARONIS SYSTEMS INC 1,543 2,266
043436104 ASBURY AUTOMOTIVE GR 1,215 1,215
03027X100 AMERICAN TOWER CORP 156,583 125,636
55405Y100 MA COM TECH SOLUTION    
127203107 CACTUS INC A 2,632 3,677
78463M107 SPS COMMERCE INC 33,521 37,350
05478C105 AZEK CO INC CL A    
43283X105 HILTON GRAND VACATIO 1,543 1,402
674215207 CHORD ENERGY CORPORA    
30063P105 EXACT SCIENCES CORPO 380,339 221,838
56585A102 MARATHON PETROLEUM C 156,770 437,891
353514102 FRANKLIN ELEC INC 1,295 1,462
86614U100 SUMMIT MATERIALS INC 2,024 3,694
98139A105 WORKIVA INC    
971378104 WILLSCOT MOBIL MINI    
23282W605 CYTOKINETICS INC    
44925C103 ICF INTERNATIONAL IN    
68404L201 OPTION CARE HEALTH I    
243537107 DECKERS OUTDOOR CORP 9,626 40,009
67000B104 NOVANTA INC 1,438 1,680
05605H100 BWX TECHNOLOGIES INC    
184496107 CLEAN HBRS INC    
87901J105 TEGNA INC    
925050106 VERONA PHARMA PLC A 514 2,276
053611109 AVERY DENNISON CORP    
04280A100 ARROWHEAD PHARMACEUT    
Y7542C130 SCORPIO TANKERS INC    
29084Q100 EMCOR GROUP INC 12,234 36,312
423452101 HELMERICH PAYNE INC    
28618M106 ELEMENT SOLUTIONS IN 2,868 3,662
30226D106 EXTREME NETWORKS INC    
844895102 SOUTHWEST GAS HOLDIN 4,365 4,596
78709Y105 SAIA INC 20,036 31,901
G4388N106 HELEN OF TROY LTD    
127190304 CACI INTERNATIONAL I    
736508847 PORTLAND GENERAL ELE 4,192 3,795
90384S303 ULTRA SALON COSMETIC    
775133101 ROGERS CORP    
007973100 ADVANCED ENERGY INDS 3,140 3,353
01741R102 ALLEGHENY TECHNOLOGI 1,813 2,312
03209R103 AMPHASTAR PHARMACEUT    
03937C105 ARCBEST CORP 2,423 2,053
047649108 ATKORE INTERNATIONAL    
05969A105 BANCORP INC DEL    
07831C103 BELLRING DISTR LLC C    
099406100 BOOT BARN HOLDINGS I 2,700 3,796
10806X102 BRIDGEBIO PHARMA INC 1,007 1,399
115236101 BROWN BROWN INC 27,017 37,645
116794108 BRUKER CORPORATION    
14888U101 CATALYST PHARMACEUTI 1,862 2,504
15872M104 CHAMPIONX CORPORATIO    
21044C107 CONSTRUCTION PARTNER 1,211 2,654
224408104 CRANE COMPANY 19,243 31,868
23257D103 CYMABAY THERAPEUTICS    
237194105 DARDEN RESTAURANTS I    
25271C201 DIAMOND OFFSHORE DRI    
25402D102 DIGITALOCEAN HLDGS I    
26856L103 E L F BEAUTY INC    
296315104 E S C O TECHNOLOGIES    
303075105 FACTSET RESEARCH SYS 26,618 32,179
31188V100 FASTLY INC CLASS A    
346232101 FORESTAR GROUP INC 3,539 3,084
358054104 FRESHWORKS INC CLASS    
436440101 HOLOGIC INC    
498894104 KNIFE RIV HLDG CO 2,577 4,472
513847103 LANCASTER COLONY COR 2,557 2,597
52661A108 RADA ELECTR INDS LTD 2,485 4,750
558868105 MADRIGAL PHARMACEUTI    
59001A102 MERITAGE HOMES CORPO 2,334 2,461
59100U108 PATHWARD FINANCIAL I 4,270 5,592
65290E101 NEXTRACKER INC CLASS    
683344105 ONTO INNOVATION INC 30,656 24,667
691497309 OXFORD INDS INC    
69404D108 PACIFIC BIOSCIENCES    
71375U101 PERFICIENT INC    
71424F105 PERMIAN RESOURCES CO    
74366E102 PROTAGONIST THERAPEU 945 1,274
750917106 RAMBUS INC 1,449 1,374
77313F106 ROCKET PHARMACEUTICA    
78440X887 SL GREEN REALTY CORP 2,605 4,075
80874P109 SCIENTIFIC GAMES COR    
825704109 SI BONE INC    
82900L102 SIMPLY GOOD FOODS CO 2,664 2,807
829073105 SIMPSON MFG CO INC 1,871 2,322
830940102 SKYWARD SPECIALTY IN 2,779 4,195
85254J102 STAG INDUSTRIAL INC    
86800U104 SUPER MICRO COMPUTER    
89377M109 TRANSMEDICS GROUP IN    
896945201 TRIPADVISOR INC COM    
92047W101 VALVOLINE INC 27,831 25,688
92243G108 VAXCYTE INC COM 1,831 2,210
942749102 WATTS WATER TECHNOLO 25,938 30,698
G01767105 ALKERMES PLC 1,392 1,409
G25457105 CREDO TECHNOLOGY GRO 789 2,420
G3323L100 FABRINET 1,428 1,539
G6700G107 NVENT ELECTRIC PLC 22,330 27,196
G8068L108 SHARKNINJA INC    
005098108 ACUSHNET HOLDINGS CO 2,388 2,559
02553E106 AMERICAN EAGLE OUTFI 34,086 26,205
030506109 AMERICAN WOODMARK CO 1,793 1,432
038336103 APTAR GROUP INC 31,719 31,420
03940C100 ARCELLX INC COMMON S 346 460
03957W106 ARCHROCK INC 2,121 2,016
04956D107 ATMUS FILTRATION TEC 1,923 2,547
05379B107 AVISTA CORP 2,555 2,381
126402106 CSW INDUSTRIALS INC 1,800 2,470
12740C103 CADENCE BANK COM 4,720 5,512
141788109 CARGURUS INC 2,187 2,156
147528103 CASEYS GEN STORES IN 26,900 34,076
185123106 CLEARWATER ANALYTICS 4,817 5,724
216648501 COOPER COS INC COM 11,981 27,211
21874A106 CORE SCIENTIFIC INC 2,580 2,445
22663K107 CRINETICS PHARMACEUT 3,438 3,886
231561101 CURTISS WRIGHT CORP 30,689 39,036
249906108 DESCARTES SYS GROUP 32,335 38,851
252131107 DEXCOM INC 31,202 31,575
268150109 DYNATRACE INC 35,334 33,371
28036F105 EDGEWISE THERAPEUTIC 2,393 2,643
292765104 ENERPAC TOOL GROUP C 2,385 2,548
300426103 EVERUS CONSTR GROUP 2,083 2,236
35905A109 FRONTDOOR INC 2,312 2,952
380237107 GODADDY INC CLASS A 32,952 32,763
40637H109 HALOZYME THERAPEUTIC 35,867 27,586
42226A107 HEALTHEQUITY INC 2,093 2,495
457669307 INSMED INC 1,256 1,174
45780R101 INSTALLED BUILDING P 2,388 1,928
458334109 INTER PARFUMS INC 2,477 2,762
46116X101 INTRA CELLULAR THERA 2,312 2,673
465741106 ITRON INC COM 2,491 2,497
50127T109 KURA ONCOLOGY INC 1,444 714
516544103 LANTHEUS HOLDINGS IN 1,934 1,521
52110M109 LAZARD INC COM 2,410 2,523
53263P105 LIMBACH HOLDINGS INC 2,808 2,481
53947R105 LOAR HOLDINGS INC 2,282 3,400
55405W104 MYR GROUP INC DEL CO 2,143 2,232
559663109 MAGNOLIA OIL GAS COR 4,128 3,811
57060D108 MARKETAXESS HLDGS IN 32,851 25,769
607828100 MODINE MFG CO COM W/ 1,860 2,435
62482R107 MR COOPER GROUP INC 3,412 4,128
630402105 NAPCO SEC TECHNOLOGI 2,261 1,600
63947X101 NCINO INC COM 2,105 2,082
671044105 O S I SYS INC 2,555 3,014
681116109 OLLIES BARGAIN OUTLE 30,893 35,772
69370C100 PTC INC 29,465 30,339
69753M105 PALOMAR HOLDINGS INC 3,251 3,379
70975L107 PENUMBRA INC 30,082 37,759
724078100 PIPER SANDLER CO 2,483 3,599
74006W207 PRAXIS PRECISION MED 1,023 1,385
74624M102 PURE STORAGE INC CLA 30,528 35,629
78454L100 SM ENERGY CO 3,546 2,946
80706P103 SCHOLAR ROCK HOLDING 379 648
816850101 SEMTECH CORP COM 1,967 1,856
834203309 SOLENO THERAPEUTICS 890 764
85208M102 SPROUTS FARMERS MARK 33,244 27,955
912008109 US FOODS HOLDING COR 31,368 36,361
91678A107 UPSTREAM BIO INC 1,077 641
92790C104 VIRIDIAN THERAPEUTIC 681 613
928254101 VIRTU FINANCIAL INC 3,347 4,567
92846Q107 VITA COCO CO INC 1,467 2,067
950755108 WERNER ENTERPRISES I 1,282 1,185
G3730V105 FTAI AVIATION LTD SH 896 2,161
G48833118 WEATHERFORD INTL LTD 32,281 19,340
G5S37H101 MAREX GROUP PLC ORD 2,139 2,182
H8088L103 SPORTRADAR GROUP AG 1,395 1,370
N5749R100 MERUS NV 855 673
N62509109 NEWAMSTERDAM PHARMA 750 1,002
Y95308105 WAVE LIFE SCIENCES P 1,552 2,585

TY 2024 InvestmentsOtherSchedule2
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Category/ Item Listed at Cost or FMV Book Value End of Year Fair Market Value
97MSCX7K5 CARLYLE PRIVATE EQUI AT COST 264,666 275,958
77957Y106 T ROWE PRICE MID CAP AT COST 759,867 668,608
56063J344 MAINSTAY FLOATING RA      
19765P596 COLUMBIA SMALL CAP G      
06828M876 BARON EMERGING MARKE AT COST 309,518 359,584
13161T401 CALVERT SHORT DURATI AT COST 572,514 564,538
922042858 VANGUARD FTSE EMERGI AT COST 353,045 357,076
77954Q106 T ROWE PRICE BLUE CH AT COST 45,087 83,188
025083874 AMERICAN CENT ULTRA AT COST 154,894 348,266
74440B884 PGIM TOTAL RETURN BO AT COST 925,539 868,454
412295107 HARDING LOEVNER INTE AT COST 840,921 862,418
025076878 AMERICAN CENTURY REA      
921910501 VANGUARD INTERNATION AT COST 825,942 868,951
464288521 ISHARES CORE US REIT AT COST 239,090 255,603
02508F828 AMERICAN CENTURY REA AT COST 141,694 126,165
04314H568 ARTISAN HIGH INCOME AT COST 550,000 558,594
19765Y340 COLUMBIA SMALL CAP G AT COST 320,000 307,531
861728400 STONE RIDGE HY REINS AT COST 400,000 394,714
949915482 ALLSPRING SPECIAL MI AT COST 100,000 92,716

TY 2024 OtherAssetsSchedule
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Description Beginning of Year - Book Value End of Year - Book Value End of Year - Fair Market Value
000000000 MISCELLANEOUS ENTRY 14,490 11,508 11,508


TY 2024 OtherDecreasesSchedule
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Description Amount
COST BASIS ADJ 1,781


TY 2024 OtherExpensesSchedule
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Description Revenue and Expenses per Books Net Investment Income Adjusted Net Income Disbursements for Charitable Purposes
ADVISORY COMMITTEE FEES 21,000 0   21,000
STATE FILING FEE/TAX 25 0   25
ADR FEES 5 5   0
MISCELLANEOUS EXPENSES 5,563 0   5,563


TY 2024 OtherIncomeSchedule2
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Description Revenue And Expenses Per Books Net Investment Income Adjusted Net Income
CARLYLE PE DISTRIBUTIONS 16,542 16,542  
OTHER INCOME 695 695  


TY 2024 OtherProfessionalFeesSchedule
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Category Amount Net Investment Income Adjusted Net Income Disbursements for Charitable Purposes
OTHER EXPENSE (NON-DEDUCTIBLE 4,318     4,318


TY 2024 TaxesSchedule
Name:
DONALD WEESNER CHARITABLE TR UA
EIN:
41-6463406
Category Amount Net Investment Income Adjusted Net Income Disbursements for Charitable Purposes
FOREIGN TAXES 5,882 5,882   0
FEDERAL TAX PAYMENT - PRIOR YE 495 0   0
FEDERAL ESTIMATES - PRINCIPAL 5,695 0   0
FOREIGN TAXES ON NONQUALIFIED 2,468 2,468   0